3D Printing Medical Devices market Trends, Analysis by 2035

This article summarizes the key findings from the Roots Analysis report, focusing on market size, growth drivers, segmentation, application areas, challenges, and leading players.



Market Growth Projections

- Current Market Size: The market was valued at USD 3.64 billion in 2024 and is projected to reach USD 4.37 billion in 2025.
- 2035 Forecast: By 2035, the market is expected to grow to USD 18.84 billion, reflecting a compound annual growth rate (CAGR) of 15.7% over the forecast period.



Drivers of Growth

- Patient-Specific Treatment: The shift toward personalized medicine is a major driver, as 3D printing enables the creation of custom implants, prosthetics, and surgical guides tailored to individual patients.
- Rising Surgical Procedures: Increased prevalence of surgeries, especially for orthopedic and dental applications, is boosting demand for 3D-printed medical devices.
- Technological Advancements: Innovations in 3D printing, such as bioprinting and the integration of artificial intelligence (AI), are expanding the range of possible applications and improving device precision.
- Cost and Time Efficiency: 3D printing reduces both production time and costs compared to traditional manufacturing methods, making it attractive for medical device manufacturers.



Market Segmentation

The market is segmented across several dimensions:

- Type of Component: Software and services, equipment, 3D printers, 3D bioprinters, and biomaterials. Currently, 3D printers hold the largest share (40%), but 3D bioprinters and biomaterials are expected to grow at a higher CAGR.
- Type of Product: Dental products, cardiovascular products, neurological products, orthopedic products, cranio-maxillofacial products, and other products. Orthopedic products dominate the market due to the demand for patient-specific implants.
- Type of Raw Material: Plastics (thermoplastics and photopolymers), biomaterial inks, metals and alloys, ceramics, paper, wax, and other materials. Metals and alloys currently lead, but plastics are projected to grow faster.
- Type of Technology: Laser beam melting (including direct metal laser sintering, selective laser sintering, selective laser melting, and laserCUSING), photopolymerization (digital light processing, stereolithography, two-photon polymerization, and PolyJet 3D printing), droplet deposition/extrusion-based technologies (fused deposition modeling, multiphase jet solidification, low-temperature deposition manufacturing, and microextrusion bioprinting), electron beam melting, three-dimensional printing/adhesion bonding/binder jetting, and other technologies. Laser beam melting holds the largest share, but electron beam melting is expected to grow rapidly.
- Application: Surgical guides (dental, craniomaxillofacial, orthopedic, and spinal), surgical instruments (fasteners, scalpels, retractors), standard prosthetics & implants, custom prosthetics & implants (orthopedic, dental, craniomaxillofacial), tissue-engineered products (bone & cartilage scaffolds, ligament & tendon scaffolds), hearing aids, wearable medical devices, and other applications. Custom prosthetics & implants currently lead, but surgical guides and tissue-engineered products are expected to grow fastest.
- End User: Hospitals and surgical centers, dental and orthopedic clinics, academic institutions and research laboratories, pharmaceutical/biotechnology and medical device companies, and clinical research organizations. Hospitals and surgical centers hold the largest share, but pharmaceutical/biotechnology and medical device companies are expected to grow at a higher CAGR.
- Geographical Region: North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America. North America leads the market, but Asia-Pacific is expected to grow at the highest CAGR.



Application Areas

- Surgical Planning and Execution: 3D printing is used to create anatomical models for presurgical planning and surgical guides for precise execution.
- Custom Implants and Prosthetics: The technology enables the production of patient-specific implants and prosthetics, improving treatment outcomes.
- Tissue Engineering and Regenerative Medicine: 3D bioprinting supports the development of tissue-engineered products and organ prototypes for research and regenerative medicine.
- Drug Development: Organ-on-a-chip models and tissue scaffolds are used to evaluate drug efficacy and safety.



Challenges

- High Costs: The initial investment and maintenance costs for 3D printing technology are significant.

Thank you for reading Roots Analysis report. Kindly get in touch with Roots’ team to know more about the report or to receive a customized copy of it. Our team will ensure the report is tailored according to your needs.

About Roots Analysis

Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.